A Systematic Review of Patient-Reported Outcome Measurement for Psoriasis in Chinese Population  

作　　者：Li Kexin Zhang Fang Huang Zhe 

机构地区：[1]School of Business Administration,Shenyang Pharmaceutical University,Shenyang 110016,China [2]ZTE Foundation,Shenzhen 518055,China

出　　处：《Asian Journal of Social Pharmacy》2023年第3期261-280,共20页亚洲社会药学（英文）

摘　　要：Objective To review the development of patient-reported outcome measurement(PROM)for patients with psoriasis in China,and to analyze the main results and methodology.Methods The systematic review method of COSMIN(consensus-based standards for the selection of health measurement instruments)was adopted,and the domestic and foreign databases were searched to find the patient-reported outcome scales based on Chinese psoriasis patients.Then,the included studies were evaluated by using COSMIN risk of bias checklist.Results and Conclusion A total of 3 studies were included,involving 3 scales.We found that the quality evaluation of the development process of the 3 scales was not high,and there were large methodological loopholes in the whole cycle of scale development and verification.The included studies have many problems such as low extrapolation,poor quality,and lack of validation,which can provide more insights for the quality control requirements of the whole cycle of scale development in the future.

关 键 词：PSORIASIS health related quality of life(HRQOL) patient-reported outcome RELIABILITY validity 

分 类 号：R75[医药卫生—皮肤病学与性病学]